危重症患者的风险分层：成人呼吸窘迫综合征中的生长分化因子-15评分
Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome.
作者信息
Kempf Tibor, Wollert Kai C
出版信息
Crit Care. 2013 Jul 31;17(4):173. doi: 10.1186/cc12765.
Abstract
Patients with adult respiratory distress syndrome (ARDS) are highly heterogeneous but current therapies are rather uniform and largely supportive. In the previous issue of Critical Care, Clark and colleagues report that the biomarker GDF-15 provides prognostic information in ARDS that is additive to that provided by the APACHE III score. Patients with high levels of growth-differentiation factor 15 (GDF-15) had a higher mortality and more complicated hospital course. Biomarkers such as GDF-15 may help us to identify patients at higher risk who may eventually benefit from more personalized and targeted therapies.
摘要
患有成人呼吸窘迫综合征（ARDS）的患者具有高度异质性，但目前的治疗方法较为统一且主要是支持性的。在上一期《重症监护》杂志中，克拉克及其同事报告称，生物标志物生长分化因子15（GDF-15）在ARDS中提供的预后信息是对急性生理与慢性健康状况评分系统Ⅲ（APACHE III）评分所提供信息的补充。生长分化因子15（GDF-15）水平较高的患者死亡率更高，住院过程也更复杂。诸如GDF-15这样的生物标志物可能有助于我们识别出风险较高的患者，这些患者最终可能会从更个性化、更具针对性的治疗中获益。
相似文献
1
Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndrome.危重症患者的风险分层：成人呼吸窘迫综合征中的生长分化因子-15评分
Crit Care. 2013 Jul 31;17(4):173. doi: 10.1186/cc12765.
2
Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study.生长分化因子-15与急性呼吸窘迫综合征的预后：一项回顾性队列研究
Crit Care. 2013 May 24;17(3):R92. doi: 10.1186/cc12737.
3
[The value of growth differentiation factor-15 and extravascular lung water index in severity grading of acute respiratory distress syndrome patients and their prognosis prediction].生长分化因子-15及血管外肺水指数在急性呼吸窘迫综合征患者严重程度分级及预后预测中的价值
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Oct;32(10):1226-1230. doi: 10.3760/cma.j.cn121430-20200407-00257.
4
Development of a biomarker mortality risk model in acute respiratory distress syndrome.急性呼吸窘迫综合征生物标志物死亡风险模型的建立。
Crit Care. 2019 Dec 16;23(1):410. doi: 10.1186/s13054-019-2697-x.
5
Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.生长分化因子 15：一种新型风险标志物，可辅助 EuroSCORE 对心脏手术患者进行风险分层。
J Am Coll Cardiol. 2013 Feb 12;61(6):672-81. doi: 10.1016/j.jacc.2012.09.059.
6
Growth-differentiation factor-15 in heart failure.心力衰竭中的生长分化因子-15
Heart Fail Clin. 2009 Oct;5(4):537-47. doi: 10.1016/j.hfc.2009.04.006.
7
Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock.生长分化因子 15 水平与心源性休克的早期死亡风险分层。
J Card Fail. 2019 Nov;25(11):894-901. doi: 10.1016/j.cardfail.2019.07.003. Epub 2019 Jul 13.
8
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.生长分化因子 15，一种氧化应激和炎症的标志物，用于评估心房颤动患者的风险：来自心房颤动患者中阿哌沙班减少卒中和其他血栓栓塞事件（ARISTOTLE）试验的结果。
Circulation. 2014 Nov 18;130(21):1847-58. doi: 10.1161/CIRCULATIONAHA.114.011204. Epub 2014 Oct 7.
9
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas.评估 GDF-15、ABC-AF 出血评分和 ABC-AF 死亡评分在不同地理区域的房颤患者中的预后价值。
Open Heart. 2021 Mar;8(1). doi: 10.1136/openhrt-2020-001471.
10
Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.白细胞介素6、半乳糖凝集素3、生长分化因子15和可溶性ST2对危重症患者死亡率的预测作用
J Crit Care. 2016 Aug;34:38-45. doi: 10.1016/j.jcrc.2016.03.020. Epub 2016 Mar 30.
引用本文的文献
1
Imperatorin ameliorates pulmonary fibrosis via GDF15 expression.欧前胡素通过生长分化因子15（GDF15）的表达改善肺纤维化。
Front Pharmacol. 2023 Dec 4;14:1292137. doi: 10.3389/fphar.2023.1292137. eCollection 2023.
2
Associations between Sex Hormones and Circulating Growth Differentiation Factor-15 in Male Patients with Major Depressive Disorder.男性重度抑郁症患者性激素与循环生长分化因子-15之间的关联
Brain Sci. 2021 Dec 7;11(12):1612. doi: 10.3390/brainsci11121612.
3
Role of Growth Differentiation Factor 15 in Lung Disease and Senescence: Potential Role Across the Lifespan.生长分化因子15在肺部疾病和衰老中的作用：贯穿生命周期的潜在作用
Front Med (Lausanne). 2020 Dec 3;7:594137. doi: 10.3389/fmed.2020.594137. eCollection 2020.
4
Sex-specific differences in the modulation of Growth Differentiation Factor 15 (GDF15) by hyperoxia in vivo and in vitro: Role of Hif-1α.体内和体外高氧对生长分化因子15（GDF15）调节的性别特异性差异：缺氧诱导因子-1α（Hif-1α）的作用
Toxicol Appl Pharmacol. 2017 Oct 1;332:8-14. doi: 10.1016/j.taap.2017.07.016. Epub 2017 Jul 20.
5
Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.生长分化因子 15 是一种新型的线粒体疾病诊断生物标志物。
Mol Neurobiol. 2017 Dec;54(10):8110-8116. doi: 10.1007/s12035-016-0283-7. Epub 2016 Nov 26.
6
Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo.生长分化因子-15与慢性阻塞性肺疾病中的肌肉量相关，并在体内促进肌肉萎缩。
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):436-48. doi: 10.1002/jcsm.12096. Epub 2015 Dec 29.
7
Role of GDF15 (growth and differentiation factor 15) in pulmonary oxygen toxicity.生长分化因子15（GDF15）在肺部氧中毒中的作用。
Toxicol In Vitro. 2015 Oct;29(7):1369-76. doi: 10.1016/j.tiv.2015.05.008. Epub 2015 May 21.
8
Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers.血清生长分化因子15水平与线粒体疾病严重程度及心肌应变相关，但与成年m.3243A>G携带者的疾病进展无关。
JIMD Rep. 2015;24:69-81. doi: 10.1007/8904_2015_436. Epub 2015 May 13.
本文引用的文献
1
Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study.生长分化因子-15与急性呼吸窘迫综合征的预后：一项回顾性队列研究
Crit Care. 2013 May 24;17(3):R92. doi: 10.1186/cc12737.
2
Interpreting incremental value of markers added to risk prediction models.解读风险预测模型中新增标志物的增量价值。
Am J Epidemiol. 2012 Sep 15;176(6):473-81. doi: 10.1093/aje/kws207. Epub 2012 Aug 8.
3
Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.循环生长分化因子-15 与非缺血性扩张型心肌病患者的心肌纤维化相关，在左心室辅助装置支持后迅速下降。
Eur J Heart Fail. 2012 Nov;14(11):1249-56. doi: 10.1093/eurjhf/hfs120. Epub 2012 Jul 26.
4
Growth differentiation factor 15 plasma levels and outcome after ischemic stroke.生长分化因子 15 血浆水平与缺血性脑卒中预后的关系。
Cerebrovasc Dis. 2011;32(1):72-8. doi: 10.1159/000328233. Epub 2011 May 25.
5
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.心力衰竭中生长分化因子-15 的连续测量：缬沙坦心力衰竭试验中与疾病严重程度和预后的关系。
Circulation. 2010 Oct 5;122(14):1387-95. doi: 10.1161/CIRCULATIONAHA.109.928846. Epub 2010 Sep 20.
6
Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study.生长分化因子-15用于稳定型和不稳定型冠心病患者的危险分层：动脉基因研究结果
Circ Cardiovasc Genet. 2009 Jun;2(3):286-92. doi: 10.1161/CIRCGENETICS.108.824870. Epub 2009 Mar 31.
7
Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension.特发性肺动脉高压中的生长分化因子-15
Am J Respir Crit Care Med. 2008 Sep 1;178(5):534-41. doi: 10.1164/rccm.200802-235OC. Epub 2008 Jun 19.
8
Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.生长分化因子-15用于急性肺栓塞患者的预后评估
Am J Respir Crit Care Med. 2008 May 1;177(9):1018-25. doi: 10.1164/rccm.200712-1786OC. Epub 2008 Feb 8.
9
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.生长分化因子-15在非ST段抬高型急性冠状动脉综合征患者中的预后价值
Circulation. 2007 Feb 27;115(8):962-71. doi: 10.1161/CIRCULATIONAHA.106.650846. Epub 2007 Feb 5.
Zotero 插件